[1] B. Bechtloff, S. Nordhoff, J. Ulrich, Pseudopolymorphs in Industrial Use, Cryst. Res. Technol. 36(2001) 1315-1328.[2] H.G. Brittain, Polymorphism and Solvatomorphism 2010, J. Pharm. Sci. 101(2010) 464-484.[3] Sudha R. Vippagunta, H.G. Brittain, D.J.W. Grant, Crystalline solids, Adv. Drug Deliv. Rev. 48(2001) 3-26.[4] J. van de Streek, All series of multiple solvates (including hydrates) from the Cambridge Structural Database, CrystEngComm 9(2007) 350-352.[5] S. Mittapalli, G. Bolla, S. Perumalla, A. Nangia, Can we exchange water in a hydrate structure:a case study of etoricoxib, CrystEngComm 18(2016) 2825-2829.[6] P. Grobelny, A. Mukherjee, G.R. Desiraju, Polymorphs and hydrates of Etoricoxib, a selective COX-2 inhibitor, CrystEngComm 14(2012) 5785-5794.[7] F.S. Murakami, K.L. Lang, C. Mendes, A.P. Cruz, M.A.S. Carvalho, M.A.S. Silva, Physicochemical solid-state characterization of omeprazole sodium:Thermal, spectroscopic and crystallinity studies, J. Pharm. Biomed. Anal. 49(2009) 72-80.[8] L. Vranicar Savanovic, Z. Ham, J. Rzen, Crystalline solvate of omeprazole sodium, WO Pat., 200613138-A2, 2006.[9] L. Li, Study on the Preparation of Omeprazole Sodium Solvates, Master's Thesis, TianJin University, TianJin, 2016.[10] Y. Bao, L. Tao, L. Li, H. Hao, J. Lv, B. Hou, New omeprazole sodium 1, 2-propylene glycol solvate contains 1,2-propylene glycol in preset molar ratio, CN Pat., 104844572-A, 2015.[11] C. Liu, L. Dang, W. Bai, R. Wang, H. Wei, Solid-liquid equilibrium of theophylline in solvent mixtures, J. Chem. Eng. Data 59(2014) 263-268.[12] Y. Wei, X. Zhang, L. Dang, H. We, Solubility and pseudopolymorphic transitions in mixed solvent:Meropenem in methanol-water solution, Fluid Phase Equilib. 349(2013) 25-30.[13] Y. Li, P.S. Chow, R.B.H. Tan, S.N. Black, Effect of water activity on the transformation between hydrate and anhydrate of carbamazepine, Org. Process. Res. Dev. 12(2008) 264-270.[14] K.J. Chavez, R.W. Rousseau, Solubility and pseudopolymorphic transitions in mixed solvents:sodium naproxen in methanol-water and ethanol-water solutions, Cryst. Growth Des. 10(2010) 3802-3807.[15] X. Wang, L. Dang, S. Black, X. Zhang, H. Wei, Influence of polymorphs on the transformation water activity of theophylline, Ind. Eng. Chem. Res. 51(2012) 2789-2796.[16] F. Tian, H. Qu, A. Zimmermann, T. Munk, A.C. Jorgensen, J. Rantanen, Factors affecting crystallization of hydrates, J. Pharm. Pharmacol. 62(2010) 1534-1546.[17] T.N.P. Nguyen, K.J. Kim, Transformation of monohydrate into anhydrous form of risedronate monosodium in methanol-water mixture, Ind. Eng. Chem. Res. 49(2010) 4842-4849.[18] C. Liu, L. Dang, W. Bai, R. Wang, H. Wei, Facile method for the prediction of anhydrate/hydrate transformation point, Ind. Eng. Chem. Res. 52(2013) 16506-16512.[19] N. Variankaval, C. Lee, J. Xu, R. Calabria, N. Tsou, R. Ball, Water activity-mediated control of crystalline phases of an active pharmaceutical ingredient, Org. Process. Res. Dev. 11(2007) 229-236.[20] H. Qu, M. Louhi-Kultanen, J. Rantanen, J. Kallas, Solvent-mediated phase transformation kinetics of an anhydrate/hydrate system, Cryst. Growth Des. 6(2006) 2053-2060.[21] C. Liu, L. Dang, Y. Tong, H. Wei, influence of polymorphs on the transformation water activity of theophylline, Ind. Eng. Chem. Res. 52(2013) 14979-14983.[22] M.D. Ticehurst, R.A. Storey, C. Watt, Application of slurry bridging experiments at controlled water activities to predict the solid state conversion between anhydrous and hydrated forms using theophylline as a model drug, Int. J. Pharm. 247(2002) 1-10.[23] A. Jayasankar, L. Roy, N. Rodriguez-Hornedo, Transformation pathways of cocrystal hydrates when coformer modulates water activity, J. Pharm. Sci. 99(2010) 3977-3985.[24] H. Zhu, D.J.W. Grant, Influence of water activity in organic solvent + water mixtures on the nature of the crystallizing drug phase.2. Ampicillin, Int. J. Pharm. 139(1996) 33-43.[25] Y. Wang, P. Sun, S. Xu, S. Du, T. Zhang, B. Yu, S. Zhang, Y. Wang, B. Gong, Solution-meditated phase transformation of argatroban:ternary phase diagram, rate-determining step, and transformation kinetics, Ind. Eng. Chem. Res. 56(2017) 4539-4548.[26] K. Kiyofumi, N. Mikiyoshi, K. Kazuo, Isobaric vapor-liquid equilibria for methanol + ethanol + water and the three constituent binary systems, J. Chem. Eng. Data 38(1993) 446-449.[27] A. Ainouz, J.R. Authelin, P. Billot, H. Lieberman, Modeling and prediction of cocrystal phase diagrams, Int. J. Pharm. 374(2009) 82-89.[28] K. Jarring, T. Larsson, B. Stensland, I. Ymen, Thermodynamic stability and crystal structures for polymorphs and solvates of formoterol fumarate, J. Pharm. Sci. 95(2006) 1144-1161.[29] J. Zhang, Y. Wang, G. Wang, H. Hao, H. Wang, Q. Luan, C. Jiang, Determination and correlation of solubility of spironolactone form Ⅱ in pure solvents and binary solvent mixtures, J. Chem. Thermodyn. 79(2014) 61-68.[30] X. Wang, Y. Qin, T. Zhang, W. Tang, B. Ma, J. Gong, Measurement and correlation of solubility of azithromycin monohydrate in five pure solvents, J. Chem. Eng. Data 59(2014) 784-791.[31] Z. Sun, H. Hao, C. Xie, Z. Xu, Q. Yin, Y. Bao, B. Hou, Y. Wang, Thermodynamic properties of Form A and Form B of florfenicol, Ind. Eng. Chem. Res. 53(2014) 13506-13512.[32] D. Zhang, Y. Wang, S. Ma, S. Wu, H. Hao, Determination of solubility and induction time of ceftazidime, J. Chem. Eng. Data 58(2013) 176-182.[33] L. Chen, L. Song, Y. Gao, A. Zhu, D. Cao, Experimental determination of solubilities and supersolubilities of 2,2',4,4',6,6'-hexanitrostilbene in different organic solvents, Chin. J. Chem. Eng. 25(2017) 809-814.[34] Q. Xia, P. Ma, Measurement and correlation for solubility of dimethyl-2,6-naphthalene dicarboxylate in organic solvents, Chin. J. Chem. Eng. 15(2007) 215-220. |